Quantcast
Last updated on April 17, 2014 at 11:32 EDT

Latest Aquavit Pharmaceuticals Inc. Stories

2014-03-23 00:21:44

DENVER, March 23, 2014 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc., a New York-based technology-driven life science company, officially launched its cutting-edge device, AQUAGOLD(®) fine touch(TM) today at the annual meeting for the American Academy of Dermatology, the world's largest dermatology meeting. http://photos.prnewswire.com/prnvar/20140323/NY88817 AQUAGOLD® fine touch(TM) is an innovative device incorporating microneedles smaller than a human hair to deliver a...

2014-03-05 16:26:08

NEW YORK, March 5, 2014 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc., a private high-tech life science company, announced today the appointment of David J. Goldberg, MD., JD. as its Chief Medical Officer. Dr. Goldberg is a renowned dermatologist and is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and facial rejuvenation techniques. Prior to joining Aquavit, Dr. Goldberg has served as President of ASLMS and is and or was on...

2014-01-28 12:29:48

KOHALA COAST, Hawaii, Jan. 28, 2014 /PRNewswire/ -- AQUAGOLD® fine touch(TM) was presented at the 2014 Winter Clinical Dermatology Conference in Hawaii during a session on "New Procedures for the Aging Face". Dr. Mark Nestor, Director of the Center for Cosmetic Enhancement® and Director of the Center for Clinical and Cosmetic Research in Aventura, Florida, introduced AQUAGOLD® fine touch(TM), a unique microneedle device that effectively and comfortably delivers small droplets of...

2013-11-05 12:28:27

NEW YORK, Nov. 5, 2013 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding preliminary agreement with Huons Co, Ltd. (KOSDAQ: 84110), a leading Korean pharmaceuticals company. The agreement formalizes the strategic partnership between the parties and gives Aquavit the worldwide, perpetual, and unlimited license for global commercialization of a cutting-edge drug-delivery system. The two companies will be...

2013-03-04 20:22:32

NEW YORK, March 4, 2013 /PRNewswire/ -- Aquavit Pharmaceuticals Inc. has announced its newest addition to its management team, Dr. David Shafer. He has been appointed Chief Medical Technology Officer and will be leading Aquavit's R&D Medical Technology for Aquavit's product pipeline. Prior to joining Aquavit, Dr. Shafer launched the world's first Vectra XT 3D Imaging System, allowing patients to view a 3D simulated breast augmentation, liposuction, mommy makeover, facelift,...

2012-10-08 15:22:43

SEOUL, South Korea and NEW YORK, Oct. 8, 2012 /PRNewswire/ -- Aquavit Life Sciences, Inc., a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc., announces together with Uniquest Corporation (KOSPI: 077500) a Memorandum Of Understanding to form an Alliance Partnership for the development, registration and manufacturing of Aquavit Pharmaceuticals' PITO-001. The MOU was signed on September 24, 2012. This Alliance Partnership represents a key commitment to realize Aquavit Pharmaceuticals'...

2012-09-21 02:23:28

NEW YORK, Sept. 21, 2012 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. and Accelrys Software Inc. (NASDAQ: ACCL), a leader in scientific innovation lifecycle management software, have formed an alliance partnership towards the development of Aquavit's PITO-001 and MAV-403 products. The partner agreement was signed on September 12, 2012. Under the terms of the partnership, Aquavit will utilize the scientifically aware Accelrys Enterprise Platform to develop advanced medical software for...

2012-08-08 10:25:08

SEOUL, South Korea and NEW YORK, Aug. 8, 2012 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. and Green Cross Corp. (006280:Korea SE), a leading biotechnology company in South Korea, signed a Memorandum of Understanding (MOU) towards establishing their strategic collaboration surrounding the development and commercialization of Aquavit's IBX-001 in Asia. The MOU signing took place at Green Cross in Seoul Korea on July 31, 2012. The MOU includes the framework for their collaboration...